Proteinase K Market is projected to reach US$ 33.4 Million by the end of 2026 | FMI

Proteinase K is a million dollar market accounting for a small portion in reagents and enzymes. Proteinase K is mainly used in contract research organisations, biotechnology companies, academic institutes, and diagnostics laboratories. In terms of revenue, the global Proteinase K market is expected to reach US$ 33.4 Mn by the end of 2026, witnessing a CAGR of 6.1%.

A plethora of factors are expected to impact the growth of the global Proteinase K market. A significant rise in research and development activities, lesser production costs, broader application of Proteinase K and good product stability and specificity of Proteinase K will give a massive push to the revenue growth of the global Proteinase K market by the end of the forecast period. A steady rise of chronic diseases and better government backed investment channels to fund advanced research and development are expected to boost the expansion of the global Proteinase K market over the period of assessment. An increasing number of research activities, soaring expenditure on personal healthcare and increasing adoption of gene therapy has been significantly high in the U.S. market in the recent years, making North America the most lucrative regional market for Proteinase K.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-2399

Global Proteinase K Market: Segmental Forecast

  • By form, the lyophilized powder form segment is anticipated to account for higher revenue share in the global Proteinase K as compared to the liquid form segment. Lyophilized powder from segment is expected to reach a market value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.3% over the forecast period. The growth in lyophilized powder form can be attributed to the increasing advantages of powder form over liquid form in case of storage and preservation of samples.
  • By application, purification of DNA & RNA segment will account for the highest revenue share in the global Proteinase K market as compared to other applications of Proteinase K. Purification of DNA & RNA segment is expected to reach a value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.5% over the forecast period.
  • By end user, the biotechnology companies segment is expected to project higher demand for Proteinase K as compared to other end user segments such as academic institutes and diagnostics laboratories. The strong growth in biotechnology companies can be attributed to an increasing use of Proteinase K in research and development and new drug discovery. The cost effectiveness of Proteinase K over other reagents is the key factor responsible for its increasing use in biotechnology companies. The biotechnology companies segment is expected to register the highest CAGR of 6.7% over the forecast period.

Global Proteinase K Market: Regional Market Projections

Demand for research in academics and funding facilities provided by the U.S government to support gene therapy and other activities for drug development is anticipated to boost the North America Proteinase K market. Followed by North America, Western Europe and APEJ are the most lucrative regions in the global Proteinase K market and are anticipated to grow by 5.7% and 6.1% respectively over the forecast period. Increasing demand for drug development, rising hereditary diseases due to changing lifestyles and growing disposable income are some of the factors expected to contribute to the growth of the global Proteinase K market.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2399

Global Proteinase K Market: Vendor Insights

Top companies profiled in the global Proteinase K market report include Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., Worthington Biochemical Corporation, Sisco Research Laboratories Pvt. Ltd, Promega Corporation, Bioline and F. Hoffmann-La Roche AG among others. Leading market players are adopting different strategies such as product launches and acquisitions to maintain their market share. For instance, in November 2015, Merck KGaA acquired Sigma-Aldrich to strengthen and expand its consumable and reagent portfolio.

Market Segmentation Form

  • Lyophilized Powder Form
  • Liquid Form

Application

  • Isolation and purification of genomic DNA & RNA
  • In Situ Hybridization
  • Mitochondria isolation
  • Enzyme Removal

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Ophthalmic Lasers Market is projected to increase from a valuation of US$ 884.3 Million in 2022 | FMI

[294 Pages Report] Technological advancements have deeply penetrated every facet of the healthcare industry, and the ophthalmic lasers market is no exception. Over the years, ophthalmic disorders such as diabetic retinopathy, refractive errors, glaucoma, cataract and age related macular degeneration (AMD) have surged exponentially. This has accelerated demand for advanced surgical procedures.

The introduction of ophthalmic laser surgery has revolutionized ophthalmic care in unprecedented ways. Majority of these technologies are being deployed in cataract surgeries, attributed to the disorder’s widespread prevalence across all continents. Advancements such femtosecond laser surgeries have proven highly instrumental in streamlining ophthalmic procedures, offering lightning speed detection of faulty tissues.

Such reduced detection and treatment timeframes act as major growth catalysts for the global ophthalmic lasers market, which is anticipated to reach a value of US$ 1.3 Bn by 2030.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-1529

Market Outlook:

Data Points Market Insights
market Value 2021 USD 838.4 Mn
market Value 2022 USD 884.3 Mn
market Value 2030 USD 1.3 Bn
CAGR 2022-2030 5.4%
Share of Top 5 Countries 60.4%
Key Players The key players in ophthalmic lasers market are Abbott Medical Optics, Inc., Alcon Inc. (Novartis AG), Bausch & Lomb Incorporated, LENSAR, LLC, NIDEK CO., LTD, iVIS Technologies, ZEISS International, Ziemer Ophthalmic Systems AG, and SCHWIND eye-tech-solutions GmbH & Co. KG.

Ophthalmic Lasers Market- Key Highlights

  • Ophthalmic lasers market shall expand steadily at a CAGR of 5.4% from 2022-2030
  • Cataract surgeries shall account for the majority share of the global ophthalmic lasers market
  • Femtosecond laser surgery to hold maximum sway throughout the forecast period
  • North America shall retain market hegemony, owing to increasing regulatory approvals for laser surgeries by authorities
  • Asia & Europe to contribute nearly identical revenue shares due to rise in surgeries amidst their geriatric population

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1529

COVID-19 Impact Analysis

The novel coronavirus pandemic will have a significantly high impact on the ophthalmic lasers market. As lockdowns and curbs continue to remain enforced, the number of footfalls across ophthalmology clinics and hospitals have declined considerably. Patient care has diminished by nearly 60%, with only emergency surgeries being permitted.

With in-patient visits becoming next to impossible, ophthalmologists are resorting to telemedicine with regards to consultation and advice to patients. A slump is anticipated in refractive and premium lens surgeries across developing economies in the long-run, attributed to cash crunches experienced by individual households due to the prolonged lockdowns.

At the same time, several countries are enforcing strict social distancing protocols and hygiene practices, keeping demand for ophthalmic laser surgeries sustained. For instance, ophthalmologists in Germany have made it a protocol to test patients requiring intravitreal injections and other procedures for COVID-19. If positive, they are redirected to emergency departments, reducing chances of infection.

“Vendors in the ophthalmic lasers landscape are striving to introduce novel product lines, equipped with multi-frequency selection modes to reduce exposure to intense laser bursts, preventing healthy tissue damage,” infers the FMI analyst.

Competition Dashboard

Prominent vendors in the ophthalmic lasers market include are ZEISS International, Nidek Inc., Bausch & Lomb Inc., Abbot Laboratories Inc., SCHWIND Eye-Tech Solutions, Ziemer Ophthalmic Systems AG, Novartis AG (Alcon), LENSAR LLC., iVIS Technologies and NKT Photonics A/S. New product launches and collaborations have helped these players acquire firm footing.

In 2018, ZEISS International rolled out its VISUFIT 1000 digital 3D centration data determination and consultation platform, offering a three-dimensional facial reconstruction which enables ophthalmologists perform precise centration processes on patients.

In July 2022, SCHWIND Eye-Tech acquired CE approval for its SCHWIND ATOS femtosecond laser, permitting eye surgeons to incorporate the technology in their SmartSight refractive surgery procedures.

More Insights on the Ophthalmic Lasers Market

A recent market study published by FMI on the ophthalmic lasers market includes the global industry analysis of 2014-2021 & opportunity assessment for 2022-2030, and delivers a comprehensive assessment of the most important market dynamics. The report provides a balanced, unbiased analysis of the overall market scenario based on product type (excimer lasers and femtosecond lasers), application (refractive surgery, cataract surgery, capsulotomy, trabeculoplasty and diagnostics), end-user (hospitals, ophthalmology clinics and ambulatory surgical centers) and region (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1529

Ophthalmic lasers market by Category

By Product :

  • Excimer Lasers
  • Femtosecond Laser

By Application :

  • Refractive Surgery
  • Cataract Surgery
  • Posterior Capsulotomy
  • Trabeculoplasty
  • Diagnostic

By End user :

  • Hospital
    • 500 Bedded+
    • 250-499 Bedded
    • Less than 250
  • Ambulatory Surgical Centers
  • Ophthalmology Clinics

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Allergy Diagnostics Market is expected to grow at an 11.3% CAGR from 2022 to 2032 | FMI

[170 Pages Report] According to ESOMAR-certified Future Market Insights’ (FMI’s) research report, the demand for allergy diagnostics has been increasing significantly due to rising incidence of allergic asthma and food allergies across the globe. As per the study, the global allergy diagnostics market is anticipated to grow at around 11.6% CAGR throughout the forecast period from 2021 to 2031.

According to the report, growing incidence of drug allergies especially from penicillin and morphine has fueled the demand for allergy diagnostics across the globe.

The report also states that increasing air pollution and lack of awareness regarding food and drug allergy in emerging and poor countries are encouraging market players towards developing cost effective allergy diagnostics kits.

According to a report published by the World Health Organization, globally around 262 million people are impacted by asthma out of which 461,000 die from asthma.

Rising demand for effective treatment and addressing causes of asthma will aid the overall expansion of the allergy diagnostics market.

Allergy diagnostics market experienced sluggish growth during the COVID-19 pandemic. This is because the pandemic led to suspension of immunological care and diverted the healthcare professional towards treating COVID patients.

In case of patients with severe asthma or other allergic reaction, virtual care and limited visiting methods were employed to restrict the human contact and stop the virus transmission.

Introduction of cost effective at-home food sensitivity and allergy diagnostic will boost the market growth in upcoming years. Such applications will reduce the burden on hospital and laboratories culminating to reduced allergy diagnostic and medical cost.

In the future, the market is anticipated to grow significantly, as majority of diagnostic laboratories and hospitals are inclining towards automated allergy diagnostics for its high effectiveness. Canada and U.S are likely to yield highly opportunistic prospects, contributing towards the overall expansion of the market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-4959

“Surge in food allergies cases along with increasing incidence of asthma in children will catapult the demand of allergy diagnostics during the forecast period,” says the FMI analyst.

Competitive Landscape

Allergy diagnostics market is highly competitive market owing to presence of global market players. Market players are employing multiple marketing techniques to expand their global outreach.

Allergy diagnostics market players are focusing towards employing organic and inorganic strategies to expand their global foothold.

Inorganic strategies include strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels.

They are also emphasizing towards faster product approvals, product development and patenting.

Prominent players operating in the allergy diagnostics market are:

  • Hitachi Chemical Co. Ltd
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • HOB Biotech Group Co
  • bioMérieux
  • Hycor Biomedical Inc.
  • Stallergenes Greer
  • R-Biopharm AG
  • Lincoln Diagnostics Inc.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-4959

Key Takeaways from FMI’s Allergy Diagnostics Market Study

  • The U.S is expected to dominate allergy diagnostics market on the back of rising incidence of skin allergies especially eczema and skin inflammation along with high rate of allergic rhinitis (hay fever) in black American population.
  • Presence of advance healthcare infrastructure, favorable government and insurance policies, and increased per capita income are key allergy diagnostics market drivers in Canada.
  • The U.K. will offer lucrative opportunities owing to increasing awareness regarding asthma and other allergic reactions like atopic eczema and hay fever. High prevalence of allergies will fuel the demand of allergy diagnostics in the country.
  • Increasing per capita income and increasing government and private funding towards spreading asthma awareness will boost the allergy diagnostics market sales in China.
  • India has low per capita income and presence of sub-par healthcare system. High prevalence of myths and stigmatic beliefs regarding asthma is one of the main factors limiting the market growth.

More Insights on the Global Allergy Diagnostics Market

In its latest report, FMI offers an unbiased analysis of the global allergy diagnostics market, providing historical data for the period of 2017-2022 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (fungal allergy diagnostic and neutral lactase enzymes), by allergen type (inhaled allergens, food allergens, and drug allergens), test type (in-vivo allergy tests and in-vitro allergy tests), and end user (diagnostic laboratories, hospitals, and academic research institutes) across North America, Latin America, Europe, East Asia, South Asia, and Middle East and Africa.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Americas COVID-19 Testing Market Key Players – Aurora Instruments Ltd., PRIMA Lab SA, Sky Medical Supplies & Equipment LLC., Sugentech, Inc.

[200 Pages Report] The market is set to expand due to frequent mutations in the virus that may lead to further outbreaks. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the COVID-19, besides offering effective patient care.

Some of the leading players in the Americas COVID-19 testing market include but are not limited to Sky Medical Supplies & Equipment LLC., Sugentech, Inc., Novacyt Group, Aurora Instruments Ltd., PRIMA Lab SA, SD Biosensor, INC., Gold Standard Diagnostics, Eurofins Technologies, Biomerieux SA, and Danaher.

According to Future Market Insights (FMI), the demand for COVID-19 testing is expected to reach a valuation of US$ 4,507.8 Mn in the Americas by the end of 2021. The pandemic is spreading on a global scale at a very high pace. It can cause various health concerns including cardiovascular diseases, kidney failure, and more.

To overcome the problems related to COVID-19, it is important to diagnose the ailment at an early stage of infection. According to the World Health Organization (WHO), more than 180 million positive cases of COVID-19 were diagnosed till June 2021. The rate of positive cases can be controlled with early diagnosis and treatment.

SARS-CoV-2 antigen rapid test kits are the most common type of test that accounted for value USD 2,903.0 Mn in 2020. It is widely accepted due to convenience, ease and rapid nature in the diagnosis process.

The demand for point of care testing is increasing due to advantages such as lower time requirements, at home services, and cost effectiveness. These factors are going to bolster the demand for point of care testing during the forecast period. For instance, on 28 July 2020, Roche announced the launch of the SARS-CoV-2 Rapid Antibody Test in collaboration with SD Biosensor Inc.

With the launch of vaccines and development of mass vaccination programs by governments, the number of COVID-19 cases is expected to drop by the end of 2021, however, it is expected that testing will continue even as lockdown in many countries will be lifted. Key players are focused on strengthening their mergers and acquisitions with new discoveries of technologies.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13636

Key Takeaways from COVID-19 Testing Services Market Study

  • SARS-CoV-2 antigen rapid test kits are expected to account for over 67% the Americas COVID-19 testing market share by 2031, owing to higher efficacy in diagnostics.
  • Hospital pharmacies accounted for more than 32% of the market share in 2021. The soaring influx of patients for treatment and intensive care support has driven growth.
  • Canada will reflect relatively steady growth with a 4.8% CAGR, driven by the matured, government funded healthcare system.
  • The U.S. will reflect fast growth at a CAGR around 5.7% through 2021-2031. U.S. holds the lead owing to, high healthcare expenditure, and the presence of leading players.
  • Brazil is the leading country in Latin America, estimated to account for about 54% of the regional share in 2021, supported by easier access to required technologies.

“The shift in focus from testing to vaccination is expected to hamper market growth in the near future. However, the focus on testing for international travel, frequent testing of medical staff and testing for patients with flu like symptoms are expected to continue aiding market growth,” says the Future Market Insight analyst.

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global COVID-19 testing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the COVID-19 testing treatment market on basis of the test type in detail, cover every aspect of the market such as Test type, sample type, distribution channel across North America and Latin America region.

Americas COVID-19 testing Market by CategoryTest Type:

  • SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits
  • SARS-CoV-2 Antigen Rapid Test Kits
  • Multiplex Real-Time RT-PCR Assay Kits

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13636

Sample Type:

  • Blood
  • Nasopharyngeal Swabs

Distribution Channel:

  • Hospital Pharmacies
  • Diagnostic Laboratories
  • Retail Pharmacies
  • Drug Store
  • Online Sales Channels

Region:

  • North America
  • Latin America

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Actinic Keratosis Treatment Market Key Players – Leo Pharma Inc., GlaxoSmithKline Plc. Nestle SA, Novartis AG, Sun Pharmaceutical Ltd.,

[275 Pages Report] Global demand for actinic keratosis treatment, majorly driven by that in the U.S. and European countries, continues to grow at a strong rate. Poised for revenues of over US$ 4 Bn by the end of 2019, the global actinic keratosis treatment market will exhibit an impressive CAGR of 7% during the forecast period (2019 – 2029).

The understanding about the nature of actinic keratosis and the potential risk of this condition progressing to squamous cell carcinoma (SCC) is improving, among patients as well as healthcare providers. Especially among the elderly, actinic keratosis remains one of the most commonly diagnosed dermatological condition that creates a continued need for efficacious treatments.

Who Is Winning?

The actinic keratosis treatment market report tracks the key market players, which includes GlaxoSmithKline Plc. Nestle SA, Novartis AG, Sun Pharmaceutical Ltd., Leo Pharma Inc. etc. Leading manufacturers in the actinic keratosis treatment market are focusing on acquisitions to enhance their product portfolio. For instance, in November 2015, Leo Pharma A/S completed the acquisition of dermatology business of Astellas Pharma. With this acquisition, the company expanded its dermatology product portfolio segment. Companies are also focusing on segment leadership. In February 2016, Cipher Pharmaceuticals Inc. launched Actikerall for the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis to mark their leadership in topical product segment.

Combination therapies such as topical fluorouracil cryotherapy, PDT and imiquimod therapy, chemical peels, and 5-FU are generally the most prescribed therapies for actinic keratosis. Convenient administration, lower potential for irritation, and systemic absorption continue to underpin their high adoption rate. Development of drugs with increased efficacy and decreased side effects that can be used as combination therapy for actinic keratosis treatment is currently the focal point of global market leaders. Biofrontera AG commercially launched its product Ameluz (2016), used in combination with PDT for actinic keratosis treatment.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3233

Development of minimally invasive drug-device combination therapies and fast track regulatory approval for pipeline drugs will be offering a completely new set of treatment options for actinic keratosis in the near future.

Key Takeaways – Actinic Keratosis Treatment Market Study

  • Growing use of topical products as the first-line preference for actinic keratosis treatment is offering huge opportunities to market players to develop and launch new topical products for actinic keratosis treatment.
  • Increasing collaboration activities by key market players of the actinic keratosis treatment market with other companies to broaden their products portfolio is anticipated to propel the actinic keratosis treatment market growth.
    • For instance, in March 2017, Galderma SA (Nestle Skin Health Company) collaborated with Colorescience, to enhance its product portfolio for aesthetic treatment.
  • Increasing product approvals of actinic keratosis treatment by regulatory bodies is expected to fuel the actinic keratosis treatment market growth.
    • For instance, in March 2018, combination of Ameluz and daylight photodynamic therapy (PDT) by Biofrontera AG got approval from the European Union.
  • The U.S. and Australia marking rise in incidence and prevalence of actinic keratosis will remain highly prominent markets for actinic keratosis treatment providers.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on actinic keratosis treatment market in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029 on the basis of treatment category (topical treatment, procedural modality, photodynamic therapy and others), disease type (clinical AK and subclinical AK)and end-user (hospitals, laser therapy centers, private dermatology clinics, spas and rejuvenation centers, cancer treatment centers, homecare) in seven key regions.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3233

Actinic Keratosis Treatment Market By Category

By Treatment Type:

  • Topical Treatment
    • 5-fluorouracil Cream
    • Diclofenac Gel
    • Imiquimod Cream
    • Ingenol mebutate Gel
  • Procedural Modality
    • Chemical Peels
    • Cryotherapy
  • Photodynamic Therapy
  • Others

By Disease Type:

  • Clinical AK
  • Subclinical AK

By End User:

  • Hospitals
  • Private Dermatology Clinics
  • Laser Therapy Centers
  • Cancer Treatment Centers
  • Spas and Rejuvenation Centers
  • Homecare

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Ultrasound Systems Market is projected to reach USD 13.2 billion by 2028 | Exclusive Report by FMI

Digitization in the healthcare sector has revamped the ultrasound systems market. The advancements in different spheres of the industry has benefited not just the patients but the market too, as the demand for medical examination has surged over the past decade. A new market research report by Future Market Insights, revolves around an in-depth and an all-inclusive analysis of Global Ultrasound Systems Market, reveals a strong growth of the market due to upgraded services provided to the patients and also the easier approach to the internal body examination witnessed with the usage of ultrasound systems.

According to the outcomes of global forecast mentioned in the report titled ‘Ultrasound Systems Market – Global Industry Analysis 2012 – 2021 and Opportunity Assessment 2022 – 2028’, the global ultrasound systems market is expected to reach a market value of over US$ 13.2 Bn by the end of 2028, growing at an impressive CAGR of 5.5% during the forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6695

Hospitals to hold largest share in Ultrasound Systems Market with highest demand for application in Radiology

Hospitals shift toward more value-oriented products, they need to operate more efficiently and productively. Similarly, a quality shift has occurred with patients, who more proactively involved in their care. Trends from the shift to value-based care include data integration and population health management. An influx of data combined with advancements in imaging helps leverage these data to not only bring further value but also apply it to broader populations. Along with the clearer and high definition pictures that are a part of ultrasound systems, there has also been an introduction to the portable machines. These are the more handy and easy to move form of ultrasound systems that have come into existence not long ago. Although the developed nations are already familiar with the technology, the market may find a higher prospects of growth in the developing regions. The market analysis has shown that hospitals hold the highest market share in the Global Ultrasound Systems Market, however diagnostics imaging and surgical centers are expected to raise a higher demand for the systems in the coming years. In terms of application the market is also dominated by Radiology as the key application area for ultrasound systems and is expected to continue growing further at a CAGR of 6.3% during the forecast period, as analyzed by FMI.

Favourable Government Policies to Benefit Start-up Companies and Independent diagnostic centers

As a move to encourage start-up companies, government of various regions like Asia Pacific and MEA have bolstered the initiatives to support the new start-ups who are entering the healthcare and medical device industry. It includes exemption of taxes for the first three years, subsidizing patent protection cost etc. The move is intended to boost the overall market for medical devices. Specifically the medical imaging market has also taken an independent position in the global market. With the betterment in services and advanced facilities related to ultrasound or any other imaging techniques, the global market is expected to witness a higher volume of independent imaging centers. The companies have also independently introduced handy and user-friendly devices in the market. GE, Philips, Samsung, Fukuda, Mindray, Hitachi, Toshiba, and Siemens, all these companies offer their own particular models.

The coming years will showcase more advanced ultrasound systems, which will provide an image clearer than 3D or 4D pictures.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6695

Key Market Segments Covered in Ultrasound systems Market Research

By Modality:

  • Cart/Trolley Based
  • Compact/Hand Held

By Application:

  • Radiology
  • Obstetrics & Gynaecology
  • Cardiology
  • Gastroenterology
  • Others

By End User:

  • Hospitals & Clinics
  • Diagnostic Imaging & Surgical Centers
  • ASCs
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Cancer Tissue Diagnostics Market Key Players : Thermo Fisher Scientific Inc., Abcam plc., BioGenex, Abbott Laboratories, F.Hoffmann-La Roche Ltd.

[250 Pages Report] The global cancer tissue diagnostics industry is hugely driven by sheer number of biomarkers used for early cancer detection from blood or plasma, while prevalence of lung, breast and prostate cancers has been another constant driving factor to the demand growth. Despite getting battered by the outbreak of the COVID-19, the industry players are coming back to track with the increase in investment in research & development (R&D) activities and focus on launching wider variety of products.

The latest revised edition on ‘cancer tissue diagnostics’ market study by Future Market Insights (FMI) provides a holistic overview of the global industry along with thorough analysis of the demand-supply patterns, and growth & restraining factors during the forecast period of 2021 to 2031. According to the report, the cancer tissue diagnostics industry will expand at close to 8.5% CAGR, while North America, Western Europe, Asia Pacific, and Latin America will remain hotspots for stakeholders in this industry. As per the report, North America will have the highest market share, more than 40%, through 2031.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-4191

Key Takeaways from Study

  • Rapid traction of immunohistochemistry (IHC) test to propel the demand growth
  • The United States to maintain its lead in the world’s biggest cancer tissue diagnostics industry North America
  • Germany to remain the major contributor to Western Europe cancer tissue diagnostics industry
  • China and India remain lucrative in the APEJ (Asia Pacific Excluding Japan) cancer tissue diagnostics industry
  • The United States, Japan, France, Italy, South Korea, and a few other countries to exhibit significant growth through 2031

“Growing inclination towards biomarker tests is anticipated to bolster the demand for cancer tissue diagnostic solutions substantially. As per the data revealed by the Organization for Economic Co-Operation and Development (OECD), the global biomarkers industry for companion diagnostics was worth US$ 8.4 Billion in 2016. As this value is forecast to rise further, the cancer tissue diagnostic solution providers are subject to higher revenue in the coming years,” says an FMI analyst.

How Rise in Cases of Cancer is Spearheading the Growth of Cancer Tissue Diagnostic Equipment Manufacturers?

According to the report on cancer published by the World Health Organization (WHO) on 3rd March, 2021, approximately 70% of deaths from cancer occur in low and middle-income countries, while cancer is the second leading cause of death globally and is responsible for approximately 10 million deaths per year. While this indicates the fatality and risks associated with cancer, it also signifies the importance of early diagnosis of cancer, which is resulting in growing adoption of timely diagnosis for various cancers such as lungs, breast, colon, and liver, to name a few.

The recent report by WHO states that late-stage presentation and lack of access to diagnosis and treatment are what make it more fatal for patients, while comprehensive treatment is reportedly available in more than 90% of high-income countries. Such reports are spreading awareness among people, which in turn is favoring the suppliers of cancer tissue diagnostics equipment.

Who is Winning in this Space?

With the competition getting stricter, key players in the global cancer tissue diagnostics industry are embracing strategic ways to launch more effective products to target broader application areas. For instance,

  • Abbott Laboratories launched its new products such as Vysis ALK Break Apart FISH Probe Kit, and others in the last 5 years
  • Bio Rad Laboratories Inc. launched its new Liquicheck™ Tumor Marker Control equipped with 3 levels and 17 cancer antigens and popular tumor markers a couple of years back

More Valuable Insights

In its latest report, FMI offers an unbiased analysis of the cancer tissue diagnostics market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of test type (immunohistochemical (IHC) test (breast cancer, stomach (gastric) cancer, colorectal cancer, prostate cancer, and others) and in situ hybridization (ISH) test (breast cancer, non-small cell lung cancer (NSCLC), bladder cancer, and others)) across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-4191

Cancer Tissue Diagnostics Market – Segmentation by CategoryTest Type

  • Immunohistochemical (IHC) Test
    • Breast Cancer
    • Stomach (Gastric) Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Others
  • In Situ Hybridization (ISH) Test
    • Breast cancer
    • Non-Small Cell Lung Cancer (NSCLC)
    • Bladder Cancer
    • Others

Region

  • North America
  • Latin America
  • Europe
  • Middle East and Africa (MEA)
  • East Asia
  • South Asia
  • Oceania

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Glamping Market is Growing Due to Surging Demand for Outdoor Recreational activities

The glamping market is estimated  to reach a valuation of US$ 10.6 Bn in 2032, Projected to grow year-on-year by 10.4% in 2022. The market size will surpass US$ 3.4 Bn in 2022, expanding at an impressive 11.8% CAGR over the assessment period.

Land adventure tourism is gaining popularity across the globe. The advent of technology and recent developments in outdoor sports activities that include optimal safety of tourists is boosting sales in the glamping market.

Due to the advent of the COVID-19 pandemic, consumers are more concerned about the safety while participating in outdoor activities. In response to this, players in the market are improving their services by adding effective personal safety protocols, thereby boosting sales.

Increasing government-backed investments in the tourism sector across the globe is a chief factor driving the glamping market. Players in the tourism sector are offering better means to attract more tourist to outdoor locations.

The uptake and integration of technologies in such locations is encouraging consumers to opt for outdoor recreational activities, thereby augmenting the growth in the market.

The developments of recreational vans and other motor homes with rental services is another factor boosting the market. Individuals are spending quality time with family and friends in remote areas and with the availability of all the resources at hand, which is emerging as a trend in the global tourism sector.

Request Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14326

Further, the higher number of tourist locations in Europe and the development of regional tourism by various countries such as Spain, France, U.K., Germany, etc., is spurring demand in the market, and the trend is expected to continue over the forecast period.

“Increasing sales of eco-pods, along with growing integration of technologies to facilitate comfort and safety in such accommodations will continue driving sales in the market over the assessment period,” says the FMI analyst.

Key Takeaways:

  • Based of product type, sales of eco-pods will remain high through 2032.
  • In terms of age group, demand in the 18-32 segment will gain traction over the forecast period.
  • By size, the 2-5 persons segment will expand at a robust pace through 2032.
  • The U.S. will continue dominating the North America glamping market.
  • Spain will emerge as a lucrative market, accounting for a dominant share in the Europe glamping market.
  • The India glamping market will continue witnessing high demand over the forecast period.

Who is winning?

Few key players in the glamping market are Bourne Leisure Holdings Limited, TENTRR, Tents Xpert, Under Canvas, The Resort at Paws Up, Collective Retreats, Asheville Glamping, GlamXperience, PurePods, Getaway House, Inc., Hoshino Resorts Inc., and Baillie Lodges among others.

Leading players operating in the global glamping market are investing in research and development to improve the quality of products and services to attract more customers.

For any Queries Related with the Report, Ask to Analyst:
https://www.futuremarketinsights.com/ask-question/rep-gb-14326

Glamping Market By Category

By Type :

  • Motor Homes
  • Tree houses
  • Eco-pods
  • Yurts
  • Tipis
  • Safari Tents
  • Bell Tents
  • Others

By Consumer Orientation :

  • Male
  • Female
  • Kids

By Age Group :

  • Below 18 years
  • 18-35 years
  • 35-50 years
  • Above 50 years

By Size :

  • Less than 2 people
  • 2-5 people
  • More than 5 people

By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Read Related Reports:

https://thegameoflife-de.mn.co/posts/26609182?utm_source=manual

https://network-66643.mn.co/posts/26609217?utm_source=manual

https://beyondher.mn.co/posts/26609220?utm_source=manual

https://synkretic.mn.co/posts/26609221?utm_source=manual

https://wecanchat.mn.co/posts/26609183?utm_source=manual

https://bipolarjungle.mn.co/posts/26609184?utm_source=manual

About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:                    

Future Market Insights,
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Pipette Tips Market is projected to surpass USD 1.47 Billion by 2032 | FMI

[333 Pages Report] The pipette tips market is worth USD 680.40 million in 2022 and is expected to grow at an 8.0% CAGR from 2022 to 2032 to reach USD 1.47 billion by 2032.

Constant product innovation, rising demand for R&D, and an increasing number of healthcare settings, diagnostics, and liquid handling systems are key drivers driving pipette tips market growth as well as the pipette tips market opportunities.

Attributes Details
Pipette Tips Market CAGR (2022-2032) 8.0%
Pipette Tips Market Size (2022) USD 680.40 million
Pipette Tips Market Size (2032) USD 1.47 billion

Furthermore, there has been an increase in the number of innovations in this product category, which is fuelling demand for pipette tips. Pipette tips, such as wide orifice tips, gel loading tips, standard, filtered, low-retention pipette tips, and so on, saw a significant increase in demand for pipette tips following the emergence of COVID-19 in 2020, as they were among the critical laboratory devices used to detect the virus’s presence.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15166

The filter tips product type segment of the pipette tips market in the United States is expected to grow at the fastest CAGR during the forecast period. The robotics segment had the largest pipette tips market share.

The demand for pipette tips increased dramatically as a result of the COVID-19 outbreak, as daily testing at diagnostic centres for infection detection increased influencing the pipette tips market adoption trends. However, many supply chain bottlenecks were encountered as demand for pipette tips outstripped supply.

Revenue from sales of pipette tips market increased significantly in the second half of 2020, particularly in the United States and Europe. Manufacturers of pipette tips are constructing a new plant for high-quality laboratory consumables made of functional high-tech polymers which will positively affect the pipette tips market key trends and opportunities as well as the pipette tips market future trends.

Eppendorf stated in its 2021 annual pipette tips market report that sales of pipette tips majorly its robotic pipetting systems have increased and have more than doubled since 2020. This suggests that demand for pipette tips notably robotic pipettes will rise as well along with the constructive effect on the pipette tips market future trends.

KEY TAKEAWAYS:

  • The standard product segment dominates the pipette tips market in product insight. It accounts for 32.5% of total revenue and is expected to grow at a healthy rate in the future.
  • In terms of technology insight, the non-robotic pipette tip segment is anticipated to have highest revenue in the pipette tips market share of 56.4% through 2032 and is expected to grow significantly during the forecast period.
  • In terms of application insight, the pharma and biotech segment dominates the pipette tips market, accounting for 32.3% of total revenue. The segment is expected to grow at the fastest CAGR during the forecast period, maintaining its leading position in the pipette tips market.
  • North America dominates the pipette tips market, accounting for 37.5% of the total revenue.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15166

COMPETITIVE LANDSCAPE:

New market research report on pipette tips will offer valuable insight into the market, with a focus on some of the major players such as Thermo Fisher Scientific, Sartorius AG, CORNING INC., Mettler Toledo, Tecan Trading AG, Hamilton Company, Eppendorf AG, and others.

Pipette tips market participants’ key strategic initiatives include new product development, collaborations, regional expansions, and mergers.

RECENT DEVELOPMENT:

Collaboration:

  • Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. announced a 15-year strategic collaboration agreement in 2022 to enable dedicated large-scale manufacturing in the United States of Spikevax, Moderna’s COVID-19 vaccine, and other investigational mRNA medicines in its pipeline, resulting in increased use of essential lab supplies such as pipette tips.

Expansion:

  • Thermo Fisher Scientific announced a $140 million investment to expand its laboratory plastics disposables production in order to meet global demand for pipette tips during COVID-19 testing, as well as for the development and manufacturing of therapies and vaccines.

Acquisition:

  • Sartorius has acquired Biological Industries Ltd., a manufacturer of cell culture and molecular biology research products.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15166

Key Segments

By Product:

  • Standard
  • Filtered
  • Low-retention
  • Others

By Technology:

  • Robotic
  • Non-robotic

By Applications:

  • Diagnostics and Healthcare
  • Pharma and Biotech
  • Academia and Education
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Faith Based Tourism Market is Expected to Grow at a 10.4% CAGR, Reaching US$ 37 Bn by 2032

The global faith based tourism market is estimated to reach a valuation of US$ 13.7 Bn in 2022. Sales are projected to increase at a 10.4% CAGR, with the market size reaching US$ 37 Bn by 2032.

The travel and tourism sector benefits from faith based tourism. Increasing preference among tourists to explore untouched heritage sites across the globe is expected to drive the market over the forecast period.

Consumers are getting inclined towards religious locations and heritage sites for a variety of reasons such as to reflect on their faith, and to better understand and respect a religion.

Religious tourism is becoming increasingly important to governments around the world, not just as a source of revenue but also as a tool for encouraging social harmony. For example, in the Buddhist Circuit, IRCTC (Indian Railway Catering and Tourism Corporation) offers a complete package that includes transportation, sightseeing, and lodging. Aside from that, airports have been built in Bodh Gaya, allowing tourists from Southeast Asian countries, who make up a substantial share of the clientele, to go directly there.

Request Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-3044

A list of Key Players Covered in the Faith Based Tourism Market are:

  • Martin Randall Travel Ltd
  • Heritage Tours & Travels
  • Best Way Tours & Safaris
  • Regina Tours
  • Travelway Europe
  • SpainTOP
  • 206 Tours Inc.
  • Maranatha Tours
  • Indus Travels Inc.
  • Brightspark Travel Inc.
  • Wendy Wu Tours
  • ACE Cultural Tours
  • Kesari Tours Pvt Ltd
  • Go Thailand Tours
  • S. Travel & Tours Co., Ltd
  • Vansol Travel & Tours
  • Catholic Travel Centre
  • Amiel Tours LTD
  • Israel Travel Providers, LLC
  • Gil Travel Group

Similarly, churches of Goa, Kerala, and Tamil Nadu will be on the Christian circuit. To foster national cohesion, the Sarv Dharma Circuit will run through Tirupathi-Chennai-Velankanni-Nagoor and Vaishnodevi-Golden Temple-Sacred Heart Church (Delhi)-Nizamuddin.

The Ministry of Tourism has already identified 35 places for Phase I, with a total of 89 destinations to be covered in Phase II. The ministry has hired consultants to help identify infrastructure and amenity shortages, assess investment requirements and potential funding sources, and develop business models for operations. Such developments are anticipated to bode well for the market over the assessment period.

“Growing preference for more authentic experiences, such as the exploration of spiritual and cultural traditions associated with specific religions and pilgrimage sites, is driving the faith-based tourism market.” says an FMI analyst.

For any Queries Related with the Report, Ask to Analyst:
https://www.futuremarketinsights.com/ask-question/rep-gb-3044

Key Takeaways:

  • Based on type, religious and heritage tours are predicted to account for a dominant share of the market through 2032.
  • In terms of consumer orientation, the women segment held 63% of the total market share in 20212, and the trend is expected to continue over the forecast period.
  • In terms of age group, demand in the 46-55 segment will continue gaining traction through 2032.
  • By booking channel, the online booking segment is anticipated to hold a noteworthy share of 48.0%.
  • Based on tour type, sales in the package segment will remain high over the forecast period.
  • Demand in. the South Asia faith based tourism market will grow at a 14% CAGR owing to increasing influx of spiritual tourists in India.
  • Canada will emerge as a lucrative pocket in North America faith based tourism market. Sales in the North America market are slated to increase at a 4.7% CAGR.

Impact of COVID-19 on the Faith Based Tourism Market

In 2020, the COVID-19 epidemic had a tremendous impact on the tourism sector due to lockdown restrictions imposed to contain the virus. According to the United Nations World Tourism Organization, international tourist arrivals (overnight visitors) decreased by 70% from January to August 2020 compared to the same time last year (UNWTO).

From January to August 2020, Asia-Pacific, which was the first to be impacted by the epidemic, saw a 79% decline in arrivals. While international travel demand continues to decline, regional tourism in several significant economies, such as China and Russia, is on the rise. Domestic tourism is contributing in the recovery of a number of locations, although only to a limited level in the majority of situations.

Global Faith Based Tourism Market by Category

By Type:

  • Day Trips & Local Gateways
  • Museums
  • Pilgrimages
  • Religious and Heritage Tours
  • Others

By Tourist Type:

  • Domestic
  • International

By Tour Type:

  • Independent Traveler
  • Tour Group
  • Package Traveller

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

Read Related Reports:

https://nethxt.mn.co/posts/26609224?utm_source=manual

https://printable-calendar.mn.co/posts/26609186?utm_source=manual

https://sharequant.tribe.so/post/adventure-tourism-market-size-growth-factors-top-leaders-trends-analysis-co–6311bb408f83b4b7dc5600fb

https://www.diigo.com/user/komalsah/b/642717902

https://domain.tribe.so/post/adventure-tourism-market-size-growth-factors-top-leaders-trends-analysis-co–6311bb4a8f83b46483560105

About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:                    

Future Market Insights,
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs